Louise Doyon

974 total citations
14 papers, 796 citations indexed

About

Louise Doyon is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Louise Doyon has authored 14 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 7 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Louise Doyon's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and Immunotherapy and Immune Responses (3 papers). Louise Doyon is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and Immunotherapy and Immune Responses (3 papers). Louise Doyon collaborates with scholars based in Canada, Egypt and United Kingdom. Louise Doyon's co-authors include Daniel Lamarre, G Croteau, Louise Pilote, Diane Thibeault, Francis Poulin, Ginette McKercher, Michael G. Cordingley, Sonia Tremblay, Elizabeth Wardrop and Léa Brakier‐Gingras and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Louise Doyon

14 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise Doyon Canada 11 585 583 143 95 76 14 796
Yasuko Sakagami Japan 12 694 1.2× 684 1.2× 285 2.0× 107 1.1× 59 0.8× 17 823
Marie K. Mankowski United States 15 345 0.6× 402 0.7× 176 1.2× 101 1.1× 59 0.8× 23 604
Barbara Van Remoortel Belgium 12 735 1.3× 745 1.3× 434 3.0× 91 1.0× 87 1.1× 18 913
Anne V. Broadhurst United Kingdom 6 591 1.0× 514 0.9× 302 2.1× 102 1.1× 216 2.8× 8 855
Alison J. Ritchie United Kingdom 9 597 1.0× 531 0.9× 416 2.9× 167 1.8× 232 3.1× 9 1.0k
T. J. MCQUADE United States 5 388 0.7× 360 0.6× 184 1.3× 55 0.6× 78 1.0× 5 539
Elizabeth Wardrop Canada 10 232 0.4× 246 0.4× 211 1.5× 166 1.7× 76 1.0× 10 578
Daniel Pauletti United States 7 536 0.9× 602 1.0× 141 1.0× 117 1.2× 57 0.8× 8 802
Marina Korneyeva United States 5 566 1.0× 525 0.9× 99 0.7× 56 0.6× 21 0.3× 7 702
C K Shih United States 6 459 0.8× 454 0.8× 245 1.7× 93 1.0× 41 0.5× 8 645

Countries citing papers authored by Louise Doyon

Since Specialization
Citations

This map shows the geographic impact of Louise Doyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Doyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Doyon more than expected).

Fields of papers citing papers by Louise Doyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Doyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Doyon. The network helps show where Louise Doyon may publish in the future.

Co-authorship network of co-authors of Louise Doyon

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Doyon. A scholar is included among the top collaborators of Louise Doyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Doyon. Louise Doyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gagnon, Alexandre, Ma’an Amad, Pierre Bonneau, et al.. (2007). Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. Bioorganic & Medicinal Chemistry Letters. 17(16). 4437–4441. 47 indexed citations
2.
O’Meara, Jeff A., Christiane Yoakim, Pierre Bonneau, et al.. (2005). Novel 8-Substituted Dipyridodiazepinone Inhibitors with a Broad-Spectrum of Activity against HIV-1 Strains Resistant to Non-nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 48(17). 5580–5588. 15 indexed citations
3.
Doyon, Louise, et al.. (2005). Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. Antiviral Research. 68(1). 27–35. 77 indexed citations
4.
Yoakim, Christiane, Pierre Bonneau, Robert Déziel, et al.. (2003). Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives. Bioorganic & Medicinal Chemistry Letters. 14(3). 739–742. 22 indexed citations
5.
White, Peter W., Steve Titolo, Karine Brault, et al.. (2003). Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction. Journal of Biological Chemistry. 278(29). 26765–26772. 57 indexed citations
6.
Doyon, Louise, et al.. (1998). Novel Gag-Pol Frameshift Site in Human Immunodeficiency Virus Type 1 Variants Resistant to Protease Inhibitors. Journal of Virology. 72(7). 6146–6150. 56 indexed citations
7.
Doyon, Louise, et al.. (1998). Induction of Endogenous Mammary Tumor Virus in Lymphocytes Infected with Murine Acquired Immunodeficiency Syndrome Virus. Cellular Immunology. 187(2). 124–130. 1 indexed citations
8.
Croteau, G, Louise Doyon, Diane Thibeault, et al.. (1997). Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. Journal of Virology. 71(2). 1089–1096. 216 indexed citations
9.
Doyon, Louise, G Croteau, Diane Thibeault, et al.. (1996). Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. Journal of Virology. 70(6). 3763–3769. 242 indexed citations
10.
Doyon, Louise, C Simard, Rafick‐Pierre Sékaly, & Paul Jolicoeur. (1996). Evidence that the murine AIDS defective virus does not encode a superantigen. Journal of Virology. 70(1). 1–9. 14 indexed citations
11.
Doyon, Louise, Zaher Hanna, Pierre Jolicœur, & Rafick‐Pierre Sékaly. (1994). Early expression of human CD4 delays thymic differentiation in transgenic mice. Research in Immunology. 145(1). 5–16. 1 indexed citations
12.
Paquette, Yves, et al.. (1992). A Viral Long Terminal Repeat Expressed in CD4+CD8+ Precursors Is Downregulated in Mature Peripheral CD4-CD8+ or CD4+CD8- T Cells. Molecular and Cellular Biology. 12(8). 3522–3530. 18 indexed citations
13.
Doyon, Louise, et al.. (1992). A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells.. Molecular and Cellular Biology. 12(8). 3522–3530. 7 indexed citations
14.
Doyon, Louise, et al.. (1990). Accessory function of human thymic dendritic cells in Con A-induced proliferation of autologous thymocyte subsets.. The Journal of Immunology. 144(3). 836–843. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026